Identification of Potential Inhibitors of MurD Enzyme of

Xiaoqi Zheng, Tongyu Zheng, Yinglin Liao, Lianxiang Luo

Open access · goldAbstract read

In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

1.0field-weighted citation impact, top 24% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

The antibacterial activity of berberine againstFrontiers in microbiology · 2023
Article
Recent developments on UDP-N-acetylmuramoyl-L-alanine-D-gutamate ligase (Mur D) enzyme for antimicrobial drug development: An emphasis on in-silico approaches.Current research in pharmacology and drug discovery · 2022
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Xiaoqi ZhengThe First Clinical College, Guangdong Medical University, Zhanjiang 524023, China.

Tongyu ZhengThe First Clinical College, Guangdong Medical University, Zhanjiang 524023, China.

Yinglin LiaoThe First Clinical College, Guangdong Medical University, Zhanjiang 524023, China.

Lianxiang LuoThe Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang 524023, China.ORCID 0000-0002-3391-9713

Guangdong Medical College · CN

Funding

Administration of Traditional Chinese Medicine of Guangdong Province 20201180;20211223Basic and Applied Basic Research Program of Guangdong Province 2019A1515110201Discipline Construction Project of Guangdong Medical University 4SG21004GInnovation and Entrepreneurship Team Leads the Pilot Program of Zhanjing 2020LHJH005Program of Department of Natural Resources of Guangdong Province No. GDNRC [2020]038 and [2021]53Science and Technology Special Project of Zhanjiang 2019A01009

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amino Acid SequenceAnti-Bacterial AgentsAquatic OrganismsBiological ProductsChemical PhenomenaDrug DiscoveryDrug Evaluation, PreclinicalEnzyme InhibitorsMolecular Docking SimulationMolecular Dynamics SimulationPeptide SynthasesSmall Molecule LibrariesStaphylococcus aureusStructure-Activity RelationshipAnti-Bacterial AgentsBiological ProductsEnzyme InhibitorsPeptide SynthasesSmall Molecule LibrariesADMEhomology modellingmolecular dynamicsS. aureus MurD enzymevirtual screening

Identifiers

PMID34770835

DOI10.3390/molecules26216426

PMCPMC8587310

OpenAlexW3208012555

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.